Roujun Peng
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 23
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
-
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 3
- Co-authors
- Shusen Wang (15 shared papers)Tao Qin (11 shared papers)Cong Xue (5 shared papers)Zhongyu Yuan (12 shared papers)Xiaoyu Teng (9 shared papers)Rongzhen Luo (1 shared paper)Zhong-Yu Yuan (8 shared papers)Shu-Sen Wang (5 shared papers)
- Journals
- Medical Oncology (4 papers)Oncotarget (3 papers)The Journal of Experimental Medicine (2 papers)Journal of Clinical Oncology (2 papers)Frontiers in Genetics (2 papers)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Roujun Peng
47 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 403
- Oncology 701
- Pathology and Forensic Medicine 332
- Immunology 319
- Genetics 115
Countries citing papers authored by Roujun Peng
This map shows the geographic impact of Roujun Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roujun Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roujun Peng more than expected).
Fields of papers citing papers by Roujun Peng
This network shows the impact of papers produced by Roujun Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roujun Peng. The network helps show where Roujun Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Roujun Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 174 | |
| 2 | 2014 | 163 | |
| 3 | 2015 | 154 | |
| 4 | 2011 | 140 | |
| 5 | 2016 | 108 | |
| 6 | 2013 | 80 | |
| 7 | 2014 | 79 | |
| 8 | 2011 | 78 | |
| 9 | 2014 | 67 | |
| 10 | 2019 | 59 | |
| 11 | 2012 | 54 | |
| 12 | 2013 | 52 | |
| 13 | 2012 | 39 | |
| 14 | 2014 | 36 | |
| 15 | 2012 | 33 | |
| 16 | 2016 | 32 | |
| 17 | 2011 | 31 | |
| 18 | 2015 | 27 | |
| 19 | 2012 | 25 | |
| 20 | 2024 | 18 |
About Roujun Peng
Roujun Peng is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (6 papers), Lymphoma Diagnosis and Treatment (5 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (4 papers), DNA Repair Mechanisms (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Cancer Research (403 citations), Oncology (701 citations), Pathology and Forensic Medicine (332 citations), Immunology (319 citations) and Genetics (115 citations). Roujun Peng has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Shusen Wang, Tao Qin, Cong Xue, Zhongyu Yuan, Xiaoyu Teng, Rongzhen Luo, Zhong-Yu Yuan, Shu-Sen Wang, Yanxia Shi and Noel F.C.C. de Miranda. Their work appears in journals such as Medical Oncology, Oncotarget, The Journal of Experimental Medicine, Journal of Clinical Oncology and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.